Side-by-side financials for ANIX and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ANIX | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #49 |
| Revenue (latest FY) | $210.00K | - |
| Net income (latest FY) | -$10.93M | - |
| Net margin | -5203.3% | - |
| SEC filings | 960 | 1,004 |
Full pages: Anixa Biosciences Inc and AstraZeneca PLC, or browse the full rankings.